Excellent clinical outcomes from a national donation-after-determination- of-cardiac-death lung transplant collaborative

Levvey, B. J., Harkess, M., Hopkins, P., Chambers, D., Merry, C., Glanville, A. R. and Snell, G. I. (2012) Excellent clinical outcomes from a national donation-after-determination- of-cardiac-death lung transplant collaborative. American Journal of Transplantation, 12 9: 2406-2413.

Attached Files (Some files may be inaccessible until you login with your UQ eSpace credentials)
Name Description MIMEType Size Downloads

Author Levvey, B. J.
Harkess, M.
Hopkins, P.
Chambers, D.
Merry, C.
Glanville, A. R.
Snell, G. I.
Title Excellent clinical outcomes from a national donation-after-determination- of-cardiac-death lung transplant collaborative
Journal name American Journal of Transplantation   Check publisher's open access policy
ISSN 1600-6135
1600-6143
Publication date 2012-09
Sub-type Article (original research)
DOI 10.1111/j.1600-6143.2012.04193.x
Volume 12
Issue 9
Start page 2406
End page 2413
Total pages 8
Place of publication Malden, MA, United States
Publisher Wiley-Blackwell Publishing
Collection year 2013
Language eng
Formatted abstract Donation-after-Determination-of-Cardiac-Death (DDCD) donor lungs can potentially increase the pool of lungs available for Lung Transplantation (LTx). This paper presents the 5-year results for Maastricht category III DDCD LTx undertaken by the multicenter Australian National DDCD LTx Collaborative. The Collaborative was developed to facilitate interaction with the Australian Organ Donation Authority, standardization of definitions, guidelines, education and audit processes. Between 2006 and 2011 there were 174 actual DDCD category III donors (with an additional 37 potentially suitable donors who did not arrest in the mandated 90 min postwithdrawal window), of whom 71 donated lungs for 70 bilateral LTx and two single LTx. In 2010 this equated to an “extra” 28% of donors utilized for LTx. Withdrawal to pulmonary arterial flush was a mean of 35.2 ± 4.0 min (range 18–89). At 24 h, the incidence of grade 3 primary graft dysfunction was 8.5%[median PaO2/FiO2 ratio 315 (range 50–507)]. Overall the incidence of grade 3 chronic rejections was 5%. One- and 5-year actuarial survival was 97% and 90%, versus 90% and 61%, respectively, for 503 contemporaneous brain-dead donor lung transplants. Category III DDCD LTx therefore provides a significant, practical, additional quality source of transplantable lungs.
Keyword Donation-after-determination-of-cardiac-death
Lung transplantation
Q-Index Code C1
Q-Index Status Confirmed Code
Institutional Status UQ
Additional Notes Article first published online: 23 JUL 2012

Document type: Journal Article
Sub-type: Article (original research)
Collections: Official 2013 Collection
School of Medicine Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 19 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 22 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Access Statistics: 44 Abstract Views, 0 File Downloads  -  Detailed Statistics
Created: Thu, 02 Aug 2012, 14:30:34 EST by Matthew Lamb on behalf of School of Medicine